Variability in Polyene Content and Cellular Toxicity Among Deoxycholate Amphotericin B Formulations
- 1 May 2003
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 23 (5) , 572-578
- https://doi.org/10.1592/phco.23.5.572.32209
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Amphotericin B–Induced Interleukin‐1β Expression in Human Monocytic Cells is Calcium and Calmodulin DependentThe Journal of Infectious Diseases, 1999
- Amphotericin B Activation of Human Genes Encoding for CytokinesThe Journal of Infectious Diseases, 1998
- Lipid Formulations of Amphotericin B: Clinical Efficacy and ToxicitiesClinical Infectious Diseases, 1998
- Pretreatment Regimens for Adverse Events Related to Infusion of Amphotericin BClinical Infectious Diseases, 1995
- Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cellsAntimicrobial Agents and Chemotherapy, 1992
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Amphotericin B Induces Tumor Necrosis Factor Production by Murine MacrophagesThe Journal of Infectious Diseases, 1989
- Induction of Prostaglandin Synthesis as the Mechanism Responsible for the Chills and Fever Produced by Infusing Amphotericin BThe Journal of Infectious Diseases, 1987
- Chemistry and biology of the polyene macrolide antibiotics.Microbiology and Molecular Biology Reviews, 1973